The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
Open accessAbstract
Clinico-pathological correlation studies and positron emission tomography amyloid imaging studies have shown that some individuals can tolerate substantial amounts of Alzheimer's pathology in their brains without experiencing dementia. Few details are known about the neuropathological phenotype of these unique cases that might prove relevant to understanding human resilience to Alzheimer's pathology. We conducted detailed quantitative histopathological and biochemical assessments on brains from non-demented individuals before death whose brains were free of substantial Alzheimer's pathology, non-demented individuals before death but whose post-mortem examination demonstrated significant amounts of Alzheimer's changes ('mismatches'), and demented Alzheimer's cases. Quantification of amyloid-β plaque burden, stereologically-based counts of neurofibrillary tangles, neurons and reactive glia, and morphological analyses of axons were performed in the multimodal association cortex lining the superior temporal sulcus. Levels of synaptic integrity markers, and soluble monomeric and multimeric amyloid-β and tau species were measured. Our results indicate that some individuals can accumulate equivalent loads of amyloid-β plaques and tangles to those found in demented Alzheimer's cases without experiencing dementia. Analyses revealed four main phenotypic differences among these two groups: (i) mismatches had striking preservation of neuron numbers, synaptic markers and axonal geometry compared to demented cases; (ii) demented cases had significantly higher burdens of fibrillar thioflavin-S-positive plaques and of oligomeric amyloid-β deposits reactive to conformer-specific antibody NAB61 than mismatches; (iii) strong and selective accumulation of hyperphosphorylated soluble tau multimers into the synaptic compartment was noted in demented cases compared with controls but not in mismatches; and (iv) the robust glial activation accompanying amyloid-β and tau pathologies in demented cases was remarkably reduced in mismatches. Further biochemical measurements of soluble amyloid-β species-monomers, dimers and higher molecular weight oligomers-in total brain homogenates and synaptoneurosomal preparations failed to demonstrate significant differences between mismatches and demented cases. Together, these data suggest that amyloid-β plaques and tangles do not inevitably result in neural system derangement and dementia in all individuals. We identified distinct phenotypic characteristics in the profile of brain fibrillar and soluble amyloid-β and tau accrual and in the glial response that discriminated demented and non-demented individuals with high loads of Alzheimer's pathology. Amyloid-β deposition in the form of fibrillar plaques and intimately related oligomeric amyloid-β assemblies, hyperphosphorylated soluble tau species localized in synapses, and glial activation emerged in this series as likely mediators of neurotoxicity and altered cognition, providing further insight into factors and pathways potentially involved in human susceptibility or resilience to Alzheimer's pathological changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“unlike in the brains of AD subjects with dementia, no phosphorylated tau accumulation occurs within the synapses of AsymAD brains [73, 83].”
From Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease (2024) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with our findings, previous studies have shown that AsymAD cases exhibit an overall deficiency in oligomeric and soluble phospho-tau species, indicating fewer pathological tau species in these cases than in AD cases [8, 73, 83].”
From Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease (2024) · cites this paper as [73]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Very few studies reported using stereology to complete their cell counts,54, 70, 83, 84, 122 the gold standard for quantifying cells in a tissue without bias.”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [83]
The cited source says what the claim attributes to it.
In the citing paper
“AsymAD brains have also been found to exhibit a neuroinflammatory profile distinct from that of AD brains, with decreased numbers of activated microglia and astrocyte cells [73]”
From Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease (2024) · cites this paper as [73]
The cited source says what the claim attributes to it.
In the citing paper
“studies have demonstrated that AsymAD brains exhibit no signs of notorious synaptic or neuronal deterioration [8, 42, 73]”
From Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease (2024) · cites this paper as [73]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The direct connection between Aβ and MAPT pathology is poorly understood, as shown by the weak correlation between the distribution of Aβ pathology and the distribution of MAPT pathology in humans (Serrano-Pozo et al., 2011; Perez-Nievas et al., 2013; Scheltens et al., 2021).”
From β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer’s disease (2024) · cites this paper as Perez-Nievas et al., 2013
Experimental — accuracy not yet measuredIn the citing paper
“Moreover, in rare instances of AD in which cognition is relatively preserved (resilient cases), the number of neurofibrillary tangles is the same as in typical AD patients, although the amount of neuronal and synaptic loss is minimal (17).”
From All the Tau We Cannot See (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Self-citationShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 5×
“Stereologically-based counts of neurofibrillary tangles, neurons, GFAP-positive astrocytes and CD68-positive microglial cells were performed as previously described (West and Gundersen, 1990; Gomez-Isla et al., 1996).”
MethodResultInfluentialSelf-citationNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Self-citationPropagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Self-citation
Cited by
Sorted by citations
Items 201–300 of 388
Croft, C. L., Kurbatskaya, K., Hanger, D. P., & Noble, W. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-07906-1 · Cited by 23
Zhu, Y., Initiative, O. B. O. A. D. N., Gong, L., He, C., Wang, Q., Ren, Q., & Xie, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190254 · Cited by 20
Hanger, D. P., Goniotaki, D., & Noble, W. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_9 · Cited by 23
Aguilar, L. F., Iulita, M. F., Orciani, C., Tanna, N., Yang, J., Bennett, D. A., & Cuello, A. C. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02169-0 · Cited by 20
Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease
Pérez-González, M., Badesso, S., Lorenzo, E., Guruceaga, E., Pérez-Mediavilla, A., García-Osta, A., & Cuadrado-Tejedor, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179120 · Cited by 16
Lee, M. J., Wang, C., Carroll, M. J., Brubaker, D. K., Hyman, B. T., & Lauffenburger, D. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.727784 · Cited by 19
Self-citationDietary High-Fat Promotes Cognitive Impairment by Suppressing Mitophagy
Wen, J., Wang, Y., Wang, C., Yuan, M., Chen, F., Zou, Q., Cai, Z., & Zhao, B. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/4822767 · Cited by 20
Antihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation
Affleck, A. J., Sachdev, P. S., Stevens, J., & Halliday, G. M. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12060 · Cited by 20
Amyloid-β predominant Alzheimer’s disease neuropathologic change
Kovacs, G. G., Katsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Forrest, S. L., Alzheimer's Disease Genetics Consortium, Bowen, J. D., Crane, P. K., Jarvik, G. P., et al. (2025) · Brain · doi:10.1093/brain/awae325 · Cited by 19
Self-citationDigital Intervention for the Management of Alzheimer’s Disease
Manchanda, N., Aggarwal, A., Setya, S., & Talegaonkar, S. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666230206124155 · Cited by 20
Kramarz, B., Roncaglia, P., Meldal, B., Huntley, R. P., Martin, M. J., Orchard, S. E., Parkinson, H., Brough, D., Bandopadhyay, R., Hooper, N. M., et al. (2018) · Genes · doi:10.3390/genes9120593 · Cited by 19
Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer’s Disease
Dionisio-Santos, D. A., Behrouzi, A., Olschowka, J. A., & O’Banion, M. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00441 · Cited by 20
Jayakody, O. M., Breslin, M. C., Stuart, K. E., Vickers, J. C., & Callisaya, M. L. (2020) · Gait & Posture · doi:10.1016/j.gaitpost.2020.08.113 · Cited by 19
The Structural Basis of Amyloid Strains in Alzheimer’s Disease
Makowski, L. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01302 · Cited by 19
Colom‐Cadena, M., Davies, C., Sirisi, S., Lee, J.-E., Simzer, E. M., Tzioras, M., Querol‐Vilaseca, M., Sánchez‐Aced, É., Chang, Y. Y., Holt, K., et al. (2023) · medRxiv · doi:10.1101/2023.03.15.23287268 · Cited by 19
Raj, A., Torok, J., & Ranasinghe, K. G. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102750 · Cited by 20
Joy, T., Rao, M. S. R., Madhyastha, S., & Pai, K. (2019) · Neuroscience Journal · doi:10.1155/2019/7547382 · Cited by 18
Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ
Matafora, V., Gorb, A., Yang, F., Noble, W. J., Bachi, A., Perez‐Nievas, B. G., & Jiménez-Sánchez, M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15875 · Cited by 19
Self-citationLv, J., Chen, L., Zhu, N., Sun, Y., Pan, J., Gao, J., Liu, J., Liu, G., & Tao, Y. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00613-3 · Cited by 18
Lennol, M. P., Canelles, S., Guerra-Cantera, S., Argente, J., García‐Segura, L. M., CEBALLOS, M. L. D., Chowen, J. A., & Frago, L. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111462 · Cited by 18
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
Merighi, S., Poloni, T. E., Pelloni, L., Pasquini, S., Varani, K., Vincenzi, F., Borea, P. A., & Gessi, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652455 · Cited by 18
Wei, W., Liu, Y., Dai, C., Baazaoui, N., Tung, Y. C., Liu, F., & Iqbal, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201599 · Cited by 17
TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice
Kim, Y., Ryu, S.-H., Hyun, J., Cho, Y.-J., & Jung, Y. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.002 · Cited by 17
Wang, S., Li, B., Solomon, V. A., Fonteh, A. N., Rapoport, S. I., Bennett, D. A., Arvanitakis, Z., Chui, H. C., Miller, C. A., Sullivan, P. M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00438-3 · Cited by 17
RetractedConsiderations for future tau-targeted therapeutics: can they deliver?
Noble, W. J., Jiménez-Sánchez, M., Perez‐Nievas, B. G., & Hanger, D. P. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1685977 · Cited by 16
Self-citationNovel monoclonal antibodies targeting the microtubule-binding domain of human tau
Croft, C. L., Moore, B. D., Ran, Y., Chakrabarty, P., Levites, Y., Golde, T. E., & Giasson, B. I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195211 · Cited by 16
Measurement Challenges in Research With Individuals With Cognitive Impairment
Kolanowski, A. M., Gilmore‐Bykovskyi, A. L., Hill, N. L., Massimo, L. M., & Mogle, J. A. (2019) · Research in Gerontological Nursing · doi:10.3928/19404921-20181212-06 · Cited by 19
Tau in the gut, does it really matter?
Derkinderen, P., Rolli‐Derkinderen, M., Chapelet, G., Neunlist, M., & Noble, W. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15320 · Cited by 16
Jiang, L., Roberts, R., Wong, M., Zhang, L., Webber, C. J., Libera, J., Wang, Z., Kilci, A., Jenkins, M., Ortiz, A. R., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1372297 · Cited by 15
Alzheimer’s disease: Pathophysiology and dental pulp stem cells therapeutic prospects
Xiong, W., Liu, Y., Zhou, H., Jing, S., He, Y., & Ye, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999024 · Cited by 15
Cognitive heterogeneity reveals molecular signatures of age-related impairment
Logan, S., Baier, M. P., Owen, D. B., Peasari, J. R., Jones, K. L., Ranjit, R., Yarbrough, H. P., Masingale, A. M., Bhandari, S., Rice, H. C., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad101 · Cited by 19
Li, H., Ye, T., Liu, X., Guo, R., Yang, X., Li, Y., Qi, D., Wei, Y., Zhu, Y., Wen, L., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.05.008 · Cited by 15
Neuroimaging of Diseases Causing Dementia
Masdeu, J. C. (2019) · Neurologic Clinics · doi:10.1016/j.ncl.2019.08.003 · Cited by 16
Tai, H., Ma, H.-T., Huang, S.-C., Wu, M., Wu, C., Lai, Y., Li, Z., Margolin, R. A., Intorcia, A. J., Serrano, G. E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.24.497452 · Cited by 15
Self-citationPilat, D. J., Le, H., Prokopenko, D., Lin, C.-C. J., Eimer, W. A., Quinti, L., Gavrilles, E. P., Garcia, S. N., Heitman, S. N., McGinty, D., et al. (2026) · Neuron · doi:10.1016/j.neuron.2025.09.032 · Cited by 14
Prediction of neuropathologic lesions from clinical data
Phongpreecha, T., Cholerton, B., Bukhari, S. A., Chang, A. L., Francesco, D. D., Thuraiappah, M., Godrich, D., Perna, A., Becker, M., Ravindra, N. G., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12921 · Cited by 14
Mi, Z., Abrahamson, E. E., Ryu, A. Y., Malek‐Ahmadi, M. H., Kofler, J., Fish, K. N., Sweet, R. A., Villemagne, V. L., Schneider, J. A., Mufson, E. J., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221063 · Cited by 15
Resilience to Alzheimer's disease associates with alterations in perineuronal nets
de Vries, L. E., Bahnerth, A., Swaab, D. F., Verhaagen, J., & Carulli, D. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14504 · Cited by 16
Buciuc, M., Whitwell, J. L., Boeve, B. F., Ferman, T. J., Graff‐Radford, J., Savica, R., Kantarci, K., Fields, J. A., Knopman, D. S., Petersen, R. C., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09718-2 · Cited by 15
Self-citationBelfiori-Carrasco, L. F., Marcora, M. S., Bocai, N. I., Ceriani, M. F., Morelli, L., & Castaño, E. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00061 · Cited by 14
Telpoukhovskaia, M. A., Hadad, N., Gurdon, B., Dai, Y., Ouellette, A. R., Neuner, S. M., Dunn, A. R., Willcox, J. A. L., Wu, Y., Dumitrescu, L. C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.487877 · Cited by 13
Ferrer‐Raventós, P., Puertollano‐Martín, D., Querol‐Vilaseca, M., Sánchez‐Aced, É., Valle‐Tamayo, N., González, A. C., Núñez‐Llaves, R., Pegueroles, J., Dols‐Icardo, O., Iulita, M. F., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12879 · Cited by 13
Self-citationHighlights of ASS234: a novel and promising therapeutic agent for Alzheimer’s disease therapy
Romero, A., Ramos, E., & Marco, J. L. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262679 · Cited by 13
Does metabolic failure at the synapse cause Alzheimer’s disease?
Engel, P. A. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.10.013 · Cited by 13
Hwang, S. J., Adluru, N., Kim, W. H., Johnson, S. C., Bendlin, B. B., & Singh, V. (2018) · Brain Connectivity · doi:10.1089/brain.2018.0590 · Cited by 14
Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins
Casaletto, K. B., Zetterberg, H., Blennow, K., Brinkmalm, A., Honer, W. G., Schneider, J. A., Bennett, D. A., Djukic, N. A., You, M. Y., Weiner‐Light, S., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012145 · Cited by 14
Lu, A., Chen, W.-T., Dalby, M., García, D. S., Vanheusden, M., de Vries, L. E., van Lieshout, V., Martirosyan, A., Craessaerts, K., Moonen, S., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04393-8 · Cited by 22
Understanding the molecular basis of resilience to Alzheimer’s disease
Montine, K. S., Berson, E., Phongpreecha, T., Huang, Z., Aghaeepour, N., Zou, J., MacCoss, M. J., & Montine, T. J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1311157 · Cited by 14
Pumo, A., & Legeay, S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148817 · Cited by 14
Cognitive resilience to Alzheimer's disease characterized by cell‐type abundance
O’Neill, N. K., Stein, T. D., Olayinka, O. A., Empawi, J. A., Hu, J., Tong, T., Zhang, X., & Farrer, L. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14187 · Cited by 15
Self-citationMolecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
Zhou, F., Zhao, Y., Sun, Y., & Chen, W. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2311197 · Cited by 13
Multiscale causal network models of Alzheimer’s disease identify VGF as a key regulator of diseasePreprint
Beckmann, N., Lin, W.-J., Wang, M.-H., Cohain, A., Wang, P., Ma, W., Wang, Y.-C., Jiang, C., Audrain, M., Comella, P., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/458430 · Cited by 12
Innate Immunity Protein IFITM3 in Alzheimer's Disease
Hur, J. (2021) · DNA and Cell Biology · doi:10.1089/dna.2021.0585 · Cited by 11
Basheer, N., Buée, L., Brion, J., Smolek, T., Muhammadi, M. K., Hritz, J., Hromádka, T., Dewachter, I., Wegmann, S., Landrieu, I., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01748-5 · Cited by 12
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
Svenningsson, A. L., Bocancea, D. I., Stomrud, E., van Loenhoud, A. C., Barkhof, F., Mattsson, N., Palmqvist, S., Hansson, O., & Ossenkoppele, R. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01591-9 · Cited by 12
Zegarra-Valdivia, J. A., Pignatelli, J., Núñez, Á., & Torres‐Alemán, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216440 · Cited by 11
Effects of Species-Specific Genetics on Alzheimer’s Mouse Models
Hyman, B. T., & Tanzi, R. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.021 · Cited by 11
Self-citationBrain Connectivity, Neural Networks, and Resilience in Aging and Neurodegeneration
Szczupak, D., Brinson, L. L., & Kolarcik, C. L. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.12.014 · Cited by 10
Lemercier, P., Vergallo, A., Lista, S., Zetterberg, H., Blennow, K., Potier, M., Habert, M., Lejeune, F., Dubois, B., Teipel, S. J., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.005 · Cited by 10
Walker, C. K., Greathouse, K. M., Tuscher, J. J., Dammer, E. B., Weber, A. J., Liu, E., Curtis, K. A., Boros, B. D., Freeman, C. D., Seo, J. V., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2102-22.2023 · Cited by 12
Targeting tau in Alzheimer’s Disease: rationale, approach and challenges
Aslanyan, A., Foiani, M. S., Giovannucci, T. A., McDade, E., Duff, K., Mummery, C. J., Schöll, M., Wildsmith, K. R., & Paterson, R. W. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00925-5 · Cited by 10
Moebius, H. J., & Church, K. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220871 · Cited by 9
Sekiyama, K., Takamatsu, Y., Koike, W., Waragai, M., Takenouchi, T., Sugama, S., & Hashimoto, M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151015 · Cited by 9
Huang, P.-Y. S., Yang, Y., Chang, Y.-H., Chang, S.-L., Chou, M., Lai, C., Liu, C., & Chen, H. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0826-6 · Cited by 10
Prenatal immune origins of brain aging differ by sex
Goldstein, J. M., Konishi, K., Aroner, S. A., Lee, H., Remington, A., Chitnis, T., Buka, S. L., Hornig, M., & Tobet, S. A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02798-w · Cited by 8
Cysteine string protein alpha accumulates with early pre-synaptic dysfunction in Alzheimer’s disease
Rupawala, H., Shah, K., Davies, C., Rose, J. L., Colom‐Cadena, M., Peng, X., Granat, L., Aljuhani, M., Mizuno, K., Troakes, C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac192 · Cited by 8
Self-citationNg, C. A. S., Biran, L. P., Galvano, E., Mandelblatt, J. S., Vicini, S., & Rebeck, G. W. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105915 · Cited by 9
Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent
Hojjati, S. H., Chiang, G. C.-Y., Butler, T., de Leon, M. J., Gupta, A. K., Li, Y., Sabuncu, M. R., Feiz, F., Nayak, S., Shteingart, J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231362 · Cited by 9
Looking at Alzheimer’s Disease Pathogenesis from the Nuclear Side
D’Andrea, L., Stringhi, R., Luca, M. D., & Marcello, E. E. (2021) · Biomolecules · doi:10.3390/biom11091261 · Cited by 8
The puzzle of preserved cognition in the oldest old
Bugiani, O. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04111-y · Cited by 8
Massachusetts Alzheimer's Disease Research Center: Progress and challenges
Hyman, B. T., Growdon, J. H., Albers, M. W., Buckner, R. L., Chhatwal, J. P., Gómez‐Isla, T., Haass, C., Hudry, E., Jack, C. R., Johnson, K. A., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.1887 · Cited by 8
Self-citationTang, F., Wei, J., Wong, M.-L., & Lei, P. (2025) · Genomic psychiatry : · doi:10.61373/gp025i.0122 · Cited by 7
McKarns, S. C. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220301104118 · Cited by 7
Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis
Padovani, A., Canale, A., Schiavon, L., Masciocchi, S., Imarisio, A., Risi, B., Bonzi, G., Giuli, V. D., Luca, M. D., Ashton, N. J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12554 · Cited by 7
Ultra-Early Screening of Cognitive Decline Due to Alzheimer’s Pathology
Wei, P. (2023) · Biomedicines · doi:10.3390/biomedicines11051423 · Cited by 7
Reduced triacylglycerols and lipid droplets are associated with resilience to Alzheimer's disease
van der Vliet, D., de Vries, L. E., Di, X., Wever, D. D., de Jong, B., van der Meij, M. T. C., van der Peet, M., Harms, A. C., Hankemeier, T., Swaab, D. F., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71083 · Cited by 6
Obesity affects brain cortex gene expression in an APOE genotype and sex dependent manner
Pandit, H., Jones, N. S., & Rebeck, G. W. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01481-y · Cited by 6
Counts, S., Beck, J. S., Maloney, B., Malek‐Ahmadi, M. H., Ginsberg, S. D., Mufson, E. J., & Lahiri, D. K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70019 · Cited by 6
Kim, S., Adams, J. N., Chappel-Farley, M. G., Keator, D. B., Janecek, J. T., Taylor, L., Mikhail, A., Hollearn, M. K., McMillan, L. C., Rapp, P. E., et al. (2023) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2023.108727 · Cited by 6
Genetic and degenerative disorders primarily causing dementia
Masdeu, J. C., & Pascual, B. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53485-9.00026-x · Cited by 6
The Challenge of Defining Alzheimer Disease Based on Biomarkers in the Absence of Symptoms
Gómez‐Isla, T., & Frosch, M. P. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.1667 · Cited by 7
Self-citationCharacteristics and Predictors of Alzheimer’s Disease Resilience Phenotype
Sin, M., Cheng, Y., Roseman, J. M., Latimer, C. S., Ahmed, A., & ZAMRINI, E. Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072463 · Cited by 6
Editorial: The Role of Glia in Alzheimer's Disease
Perez‐Nievas, B. G., & Serrano‐Pozo, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01161 · Cited by 6
Self-citationMicroglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
Resilience mechanisms underlying Alzheimer’s disease
Chew, C. S., Jy, L., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-024-01507-4 · Cited by 6
Yang, Z. X., Sheng, J., Zhang, Q., Zhao, X., Song, Y., Dong, G., Zhang, R., Zhao, H., Wang, J., Pan, R., et al. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin26584 · Cited by 7
The role of Aβ in Alzheimer's Disease as an Evolutionary Outcome of Optimized Innate Immune Defense
Tatar, M. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.68 · Cited by 6
Hiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer’s disease?
Nelson, R. B., Rose, K. N., Menniti, F. S., & Zorn, S. H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116258 · Cited by 5
Piccardo, P., & Asher, D. M. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20180111 · Cited by 5
Fagone, P., Mangano, K., Martino, G., Quattropani, M. C. A., Pennisi, M., Bella, R., Fisicaro, F., Nicoletti, F., & Petralia, M. C. (2022) · Genes · doi:10.3390/genes13040703 · Cited by 6
Investigating key factors underlying neurodegeneration linked to alpha‐synuclein spread
Pang, C. C.-C., Sørensen, M. H., Lee, K., Luk, K. C., Trojanowski, J. Q., Lee, V. M. ‐., Noble, W. J., & Chang, R. C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12829 · Cited by 4
Maderna, E., Cattaneo, C., Cacciatore, F., Catania, M., Fede, G. D., Tagliavini, F., & Giaccone, G. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140540 · Cited by 5
Resistance and Resilience to Alzheimer's DiseasePreprint
Latimer, C. S., Prater, K. E., Postupna, N. O., & Keene, C. D. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041201 · Cited by 8
Mandal, P., Trushina, E. V., Arnold, M., Kaddurah‐Daouk, R., & Baloni, P. (2026) · Communications Biology · doi:10.1038/s42003-026-10474-8 · Cited by 5
Reeling from news that reelin defends the brain against Alzheimer’s
Mouofo, E. N., & Spires‐Jones, T. L. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101111 · Cited by 4
Sánchez‐Aced, É., Moya‐Llamas, B., Escabias, J. A., Torres, S., Colom‐Cadena, M., Pegueroles, J., de Quintana-Schmidt, C. J., Bayés, À., Molina‐Porcel, L., Aldecoa, I., et al. (2025) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70010 · Cited by 4
Dávila-Bouziguet, E., Casòliba-Melich, A., Fabra, G. T., Galera-López, L., Ozaita, A., Maldonado, R. J., Ávila, J., Delgado-Garcia, J. M., Gruart, A., Soriano, E., et al. (2021) · Brain · doi:10.1093/brain/awab319 · Cited by 4
Chihara, N., Tsuji, A., & Matsumoto, R. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12747 · Cited by 4
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing micePreprint
Lam, S., Hérard, A., Boluda, S., Petit, F., Eddarkaoui, S., Cambon, K., The Brainbank Neuro-CEB Neuropathology Network, Picq, J., Buée, L., Duyckaerts, C. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.06.438654 · Cited by 4
Viral modulation of synaptic pruning: implications for neuropathology and brain function
Aliakbari, S., Asadi, S., Sayyah, M., Naderi, N., Salarvandian, S., Khodagholi, F., & Pourbadie, H. G. (2026) · Journal of Virology · doi:10.1128/jvi.01684-25 · Cited by 4
Metadata
- Authors
- Perez-Nievas, B. G., Stein, T. D., Tai, H.-C., Dols-Icardo, O., Scotton, T. C., Barroeta-Espar, I., Fernandez-Carballo, L., de Munain, E. L., Perez, J., Marquie, M., Serrano-Pozo, A., Frosch, M. P., Lowe, V., Parisi, J. E., Petersen, R. C., Ikonomovic, M. D., López, O. L., Klunk, W., Hyman, B. T., & Gómez-Isla, T.
- Affiliations
- Harvard University (US)
- Mayo Clinic (US)
- University of Pittsburgh (US)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-03
- Volume
- 136
- Issue
- 8
- Pages
- 2510-2526
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3722351
- OpenAlex
- W1978991736
- Cited by
- 387
- References
- 67
- Citations by year
- 2026: 30 · 2025: 27 · 2024: 28 · 2023: 38 · 2022: 34 · 2021: 46 · 2020: 37 · 2019: 29 · 2018: 36 · 2017: 18 · 2016: 18 · 2015: 22 · 2014: 20 · 2013: 3
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 CX001038)
- National Institutes of Health
- National Institute on Aging (AG-005133, R01AG043511, P50AG005133, U01AG016976, P50AG005134, P30AG062421, P50AG016574)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid plaques, neurofibrillary tangles, tau hyperphosphorylation, soluble amyloid-beta oligomers, synaptic integrity, axon morphology, glial activation, superior temporal sulcus, association cortex, dementia
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cognition, Humans, Neuroglia, Neurons, Phenotype, Neurofibrillary Tangles, tau Proteins, Resilience, Psychological, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
